Stay updated with breaking news from Osteosarcoma Network Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TheraVet reports its 2023 half-year results and provides an update on the development of its activities Sales increased by 29% compared to...
Sales increased by 29% compared to first half 2022Number of BIOCERA-VET units distributed1 increased by 31% compared to the first half of 2022, taking into account the successful introduction of BIOCERA-VET 3*1ccAcceleration of sales growth over the summer months of 2023 with more than 250% increase in BIOCERA-VET u...
GOSSELIES, Belgium, July 11, 2023--Regulatory News: TheraVet (ISIN: BE0974387194 - ticker: ALVET) (Paris:ALVET) (Brussels:ALVET), a pioneering company in the management of osteoarticular diseases in companion animals, provides the half-year update on its development strategy.